ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Barinthus Biotherapeutics PLC

Barinthus Biotherapeutics PLC (BRNS)

1.17
0.00
(0.00%)
Closed October 14 4:00PM
1.17
0.00
( 0.00% )
Pre Market: 4:36AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.17
Bid
1.14
Ask
1.33
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.17
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
39,414,722
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
1.88M
Net Profit
-73.35M

About Barinthus Biotherapeutics PLC

Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current proph... Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca. Show more

Sector
Offices-holdng Companies,nec
Industry
Offices-holdng Companies,nec
Headquarters
Oxfordshire, Gbr
Founded
-
Barinthus Biotherapeutics PLC is listed in the Offices-holdng Companies sector of the NASDAQ with ticker BRNS. The last closing price for Barinthus Biotherapeutics was $1.17. Over the last year, Barinthus Biotherapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Barinthus Biotherapeutics currently has 39,414,722 shares outstanding. The market capitalization of Barinthus Biotherapeutics is $46.12 million.

BRNS Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DBGIDigital Brands Group Inc
$ 0.3598
(125.16%)
5.96M
BDSXBiodesix Inc
$ 2.37
(48.13%)
40
BNZIBanzai International Inc
$ 5.28
(42.70%)
805.55k
GRTSGritstone bio Inc
$ 0.069
(27.78%)
38.15M
LIPOLipella Pharmaceuticals Inc
$ 0.5207
(27.40%)
2.63M
LGHLWLion Group Holding Ltd
$ 0.004
(-50.62%)
15.11k
QRTEBQurate Retail Inc
$ 2.14
(-44.13%)
155
STIMNeuronetics Inc
$ 0.713
(-19.89%)
1
DSYBig Tree Cloud Holdings Limited
$ 4.20
(-17.16%)
7.35k
LSBLakeShore Biopharma Company Ltd
$ 3.24
(-14.51%)
1
GRTSGritstone bio Inc
$ 0.069
(27.78%)
38.15M
ZPTAZapata Computing Holdings Inc
$ 0.0955
(24.03%)
14.18M
DBGIDigital Brands Group Inc
$ 0.3598
(125.16%)
5.96M
LIPOLipella Pharmaceuticals Inc
$ 0.5207
(27.40%)
2.63M
DJTTrump Media and Technology Group Corporation
$ 33.00
(10.18%)
1.95M

Your Recent History

Delayed Upgrade Clock